Risk Factors for Thromboembolism (TE) in Multiple Myeloma (MM) Patients (pts) Treated with Immunomodulatory Agents (IMiDs) Plus Dexamethasone (dex)
Publication details: 2018Description: 4814-4814ISSN:- 00064971
- Blood
No physical items for this record
There are no comments on this title.
Log in to your account to post a comment.